ArticlePharmaceutics2021

Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage.

Xian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.